logo-loader

Metalla closes acquisition of royalty interest in Fosterville mine

Published: 08:52 29 Sep 2020 EDT

Morgan Stanley - Metalla closes acquisition of royalty interest in Fosterville mine
Metalla has acquired a 2.5% net smelter return royalty interest for A$6 million in cash and shares

Metalla Royalty & Streaming Ltd (NYSEAMERICAN:MTA) (CVE:MTA) said it has completed its previously announced acquisition of a 2.5% net smelter return royalty interest on the northern and southern portions of Kirkland Lake Gold Ltd’s (TSE:KL) Fosterville mine in Victoria, Australia, for A$6 million, consisting of A$2 million in cash and 467,730 Metalla shares.

Fosterville is a high-grade, low-cost underground gold mine which has been in production since 2005. In 2019, the mine produced 619 kilo-ounces (koz) of gold at a grade of 39.6 grams per tonne (g/t) and a cash cost of US$119 per oz and all-in sustaining cost (AISC) of US$291 per oz. Kirkland Lake also recently reissued its guidance for 2020 at Fosterville where it anticipates producing 590 - 610koz of gold at an operating cost of US$130-US$150 per oz of gold.

WATCH: Metalla Royalty & Streaming signs agreement with Morgan Stanley for royalty on Higginsville Project

Metalla also highlighted that recent drilling in the Harrier system has continued to return encouraging results, demonstrating a sustained growth opportunity down dip and in the southern extensions. New drilling has also returned high-grade mineralization outside of the existing mineral reserves, and also demonstrated the continuity of the Harrier structure for 400 meters down plunge while remaining open at depth with an intercept of 8.1 g/t gold over 4.5 meters.

Metalla aims to provide shareholders with leveraged precious metal exposure by acquiring royalties and streams and increase its share value by “accumulating a diversified portfolio of royalties and streams with attractive returns”.

Contact the author at calum@proactiveinvestors.com

Follow him on Twitter @Cal_Proac

Xeris Biopharma Surpasses 2023 Expectations with Strategic Moves Poised for...

Xeris Biopharma CEO Paul Edick joined Steve Darling from Proactive to share news the company had a successful 2023, with a final tally of 164 million USD, which is at the upper end of their forecast. The company concluded the year with 72 million USD in cash, surpassing their initial projections...

8 hours, 34 minutes ago